Revealing the Bigger Picture Through Metadata & Building RBQM Standards of the Future
Risk-Based Monitoring is the future of clinical trials – but despite significant advances in recent years, some of the practicalities of implementation need to be…
Read More
CluePoints Sponsors RBQM Live, The Definitive Guide to RBQM for Experts and Beginners
Have you heard the news? CluePoints is sponsoring RBQM Live on behalf of the industry! The adoption of Risk-Based Quality Management (RBQM) is accelerating, and…
Read More
Centralized Monitoring: Effective Technology & Documented Evidence are the Perfect Double Act
In the world of clinical trials, if it isn’t documented, it didn’t happen. It’s a philosophy that has informed and embedded, standardized reporting approaches into…
Read More
CluePoints to Share COVID-Informed RBQM Best Practice at #SCOPE2021
It has never been more important for the clinical trial community to come together and share best practice – which is why CluePoints is delighted…
Read More
Webinar: Applying the Principles of RBQM to Data Management
The planning and execution of clinical trials is on a continuous journey to leverage the benefits of risk-based approaches and Quality by Design. Regulatory guidance…
Read More
CluePoints’ Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials
King of Prussia, PA – January 19, 2021: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials,…
Read More
Practical Steps for Centralized Monitoring Success
The successful implementation of Centralized Monitoring requires meticulous planning, process reform and alignment, cross-functional expertise, and most importantly the right technology in place. With regulators…
Read More
The Evolution of CluePoints’ SMART Engine
How C++ Revolutionized the Core of CluePoints With software playing an integral part of almost every device that makes daily life easier, the same is…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
3,400
Platform Users
700
Studies De-Risked
64,000
Issues Detected